Burlingame, CA – According to filings with the U.S. Securities and Exchange Commission, Cala Health is raising $11,999,988.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Kate Rosenbluth played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cala Health Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health’s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.

To learn more about Cala Health, visit http://www.calahealth.com/

Contact:
Kate Rosenbluth, Chief Executive Officer
415-890-3961
kate@calahealth.com
https://www.linkedin.com/in/kate-rosenbluth-72635b4/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved